STOCK TITAN

Canopy Growth (CGC) Stock News

CGC NYSE

Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.

Canopy Growth Corporation develops and sells cannabis products for adult-use and medical markets, with common shares trading as CGC on Nasdaq and WEED on the TSX. Company updates frequently cover Canadian brand activity across Tweed, Deelish, 7ACRES, DOJA, Deep Space and related formats including flower, pre-rolls, vapes, softgels and minor cannabinoid products.

News also centers on medical cannabis services through Canada House Clinics and the Abba Medix online channel, Storz & Bickel vaporization devices, operating and financial results, capital-structure actions, shareholder voting matters and governance changes. Canopy Growth also discloses its unconsolidated, non-controlling interest in Canopy USA as exposure to the U.S. THC market.

Rhea-AI Summary

Canopy Growth and Acreage Holdings have announced an amended agreement to enhance the original plan of arrangement, facilitating potential upside for shareholders. The new arrangement includes a cash payment of US$37.5 million to Acreage shareholders and introduces two new classes of shares that provide additional upside potential linked to the U.S. cannabis market. The amendments reflect current economic conditions and allow Acreage to raise capital for its hemp operations. A loan of up to US$100 million will support Acreage Hempco, with a total interest rate of 6.1%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
none
-
Rhea-AI Summary

Canopy Rivers welcomes Mike Lee, Chief Financial Officer of Canopy Growth (NYSE: CGC), to its Board of Directors. Lee's extensive experience in financial management from his previous roles will bolster Canopy Rivers' strategic execution in the global cannabis sector. His appointment signifies a deepening relationship with Canopy Growth and Constellation Brands. Canopy Rivers aims to leverage Lee's expertise to enhance its investment strategy and operational oversight, which could positively impact both companies and their portfolios as they navigate the evolving cannabis landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
management

FAQ

What is the current stock price of Canopy Growth (CGC)?

The current stock price of Canopy Growth (CGC) is $1.04 as of June 4, 2026.

What is the market cap of Canopy Growth (CGC)?

The market cap of Canopy Growth (CGC) is approximately 439.7M.